AM

ALI MCBRIDE

COHERUS BIOSCIENCES · Redwood City, CA · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
2
11 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Redwood City, CA
2024 - present

Specific issues

Domestic Manufacturing Medicare implications on biosimilars, Part D reform Drug Rebate Reform Appropriations pertaining to American Made preference HHS Supply Chain Readiness HHS Biosimilar Uptake American-Made, Security of the American Pharmaceutical and Medical Supply Chain 117 - S.2082 - Manufacturing API, Drugs, and Excipients (MADE) in America Act S.3311 - American Made Pharmaceuticals Act of 2023 FDA foreign inspections ASPR/BARDA funding and policy Interchangeability of biosimilars legislation
Health Issues · 2024 Q2
Implementation of Buy American and Supply Chain Executive Orders American-Made Policies American-Made Supply Chain Security of the American Pharmaceutical and Medical Supply Chain Biosimilars Policy BARDA funding ASPR funding ARPA-H funding and implementation Industrial Supply and Financing IRA implementation Part D biosimilars utilization
Government Issues · 2024 Q2

Clients

2024 · 2 filings
$██,███ / qtrUnlock

Filing history

2024 Q2
COHERUS BIOSCIENCES, INC.
Q2lda.gov →
2024 Q1
COHERUS BIOSCIENCES, INC.
Q1lda.gov →
Showing recent filings · full history on lda.gov